Taipei Exchange - Delayed Quote TWD

CHO Pharma, Inc. (6586.TWO)

43.00
+0.20
+(0.47%)
As of May 14 at 2:58:34 PM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,580
3,580
0
60
3,570
Cost of Revenue
1,870
1,870
0
1
211
Gross Profit
1,710
1,710
0
59
3,359
Operating Expense
251,003
251,003
268,998
350,959
213,850
Operating Income
-249,293
-249,293
-268,998
-350,900
-210,491
Net Non Operating Interest Income Expense
36,999
36,999
16,161
6,753
4,885
Pretax Income
-212,226
-212,226
-306,087
-338,393
-205,925
Net Income Common Stockholders
-212,226
-212,226
-306,087
-338,393
-205,925
Diluted NI Available to Com Stockholders
-212,226
-212,226
-306,087
-338,393
-205,925
Basic EPS
-0.99
--
-1.60
-1.84
-1.12
Diluted EPS
-0.99
--
-1.60
-1.84
-1.12
Basic Average Shares
214,369.70
--
191,304.38
183,963
183,887
Diluted Average Shares
214,369.70
--
191,304.38
183,963
183,887
Total Expenses
252,873
252,873
268,998
350,960
214,061
Net Income from Continuing & Discontinued Operation
-212,226
-212,226
-306,087
-338,393
-205,925
Normalized Income
-212,226
-212,226
-306,087
-338,393
-205,925
Interest Income
37,678
37,678
16,238
7,054
5,461
Interest Expense
679
679
77
301
576
Net Interest Income
36,999
36,999
16,161
6,753
4,885
EBIT
-211,547
-211,547
-306,010
-338,092
-205,349
EBITDA
-185,649
-185,649
-277,731
-298,242
-166,266
Reconciled Cost of Revenue
1,870
1,870
0
1
211
Reconciled Depreciation
25,898
25,898
28,279
39,850
39,083
Net Income from Continuing Operation Net Minority Interest
-212,226
-212,226
-306,087
-338,393
-205,925
Normalized EBITDA
-185,649
-185,649
-277,731
-298,242
-166,266
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers